Role of liver transplantation in human immunodeficiency virus positive patients

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 43

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 21, 2015; 21(43): 12311-12321
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12311

Table 1 Drug-drug interactions between directly acting anti-hepatitis C virus directly acting antiviral and combined anti-viral therapy

Anti-HCV DAA	cART not recommended	Dose changes
Boceprevir	Atazanavir
	Darunavir/ritonavir
	Efavirenz
	Ritonavir
Telaprevir	Darunavir	Efavirenz - dose increased
	Lopinavir/ritonavir	to 1125 mg TDS
Simeprevir	Atazanavir
	Efavirenz
	Darunavir/ritonavir
	Nevirapine
Daclatasvir	-	Efavirenz - dose increased to 90 mg OD
		Atazanavir and protease inhibitors - dose reduced to 30 mg OD
Sofosbuvir	Didanosine
	Zidovudine

DAA: Directly acting antiviral; cART: Combined anti-viral therapy; HCV: Hepatitis C virus.

Citation: Joshi D, Agarwal K. Role of liver transplantation in human immunodeficiency virus positive patients. World J Gastroenterol 2015; 21(43): 12311-12321
URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12311.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12311

Joshi D, Agarwal K. Role of liver transplantation in human immunodeficiency virus positive patients. World J Gastroenterol 2015; 21(43): 12311-12321 [PMID: 26604639 DOI: 10.3748/wjg.v21.i43.12311]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.